Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 15/20 | 0.67 |
| ▸ | NPC1 | O15118 | 14/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.65 |
| ▸ | GFER | P55789 | 2/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.65 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.65 |
| ▸ | RELA | Q04206 | 2/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 7/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MIF | P14174 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13325909 | 0.89 | RAB9A (0.83) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL13325938 | 0.87 | RAB9A (0.80) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL13131131 | 0.87 | RAB9A (0.69) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL31154574 | 0.87 | RAB9A (0.74) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL966793 | 0.87 | RAB9A (0.74) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL29080554 | 0.87 | RAB9A (0.74) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL30944801 | 0.87 | RAB9A (0.54) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL10515978 | 0.87 | RAB9A (0.54) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL25343703 | 0.86 | RAB9A (0.72) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL13325735 | 0.84 | RAB9A (0.75) | RAB9ANPC1KDM4EPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353841-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | HUFF SARAH ELIZABETH (US) | 2025-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353841-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | HTT, HYPK, ATXN2 | RAB9A 1104/4885NPC1 329/4885KDM4E 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.